The NIH has spent 10's of millions of dollars on the trial. They want it to succeed. None of the ACTIV trials have succeeded so they are desperate for a win. And it is a double blinded trial. It being sabotaged isn't realistic. We aren't in a Tom Cruise Mission Impossible movie. STAT's Matthew Herper sabotaged HGEN with his hit piece. Our share price has possibly been sabotaged by those who want to buy HGEN cheaply. The NIH isn't sabotaging us because they aren't sabotaging themselves.